AKT |
AKT-mediated S257 phosphorylation of ITCH activates its function. |
[31] |
ATM |
ATM positively modulates ITCH E3-ubiquitin ligase activity by phosphorylating ITCH on S161. |
[30] |
FYN |
Tyrosine phosphorylation of ITCH at Y420 by FYN inhibits ITCH activity. |
[32] |
Herpes simplex virus UL56 |
UL56 interacts with Itch, independent of additional viral proteins, and mediates degradation of Itch. |
[189] |
IKKα, IKKβ |
ITCH is phosphorylated on S687 by IKKs, which suppresses ITCH activity |
[190] |
JNK |
JNK phosphorylates ITCH at S240, S263, and T273 to promote ITCH-mediated JUNB ubiquitination and subsequent degradation |
[29] |
LRAD3 |
LRAD3 contains two PPxY and functions similarly as NDFIPs to alter ITCH inhibitory conformation |
[37] |
miR-106b |
hsa-miR-106b, which itself is down regulated in metastatic pancreatic cancer, directly interacts and inhibit ITCH expression |
[191,192] |
N4BP1 |
N4BP1 association with the second WW domain (WW2) of ITCH interferes with E3 binding to its substrates, hence suppresses Itch activity |
[175] |
NDFIP1, NDFIP2 |
WW domains 2 and 3 of Itch bind to the HECT domain, mediating autoinhibition. NDFIPs bind multiple WW domains through its PY motifs and relieve this autoinhibition, leaving other WW domains available to recruit substrate. |
[25,26,27,36] |
NF-κB p65 |
Overexpression of NF-κB p65 increased ITCH expression, and RANKL promoted the binding of p65 onto the NF-κB binding sites in the ITCH promoter. |
[193] |
SGK3/CISK |
SGK3 phosphorylates ITCH at T385 and S450 to suppress ITCH acitivity. |
[33] |
Spartin |
Spartin acts as an adaptor protein that activates and recruits ITCH to lipid droplets and by this means regulates the level of ubiquitination of adipophilin and potentially other lipid-associated proteins. |
[194] |
USP9X |
Functions as the DUB to antagonize the proteolytic ITCH autoubiquitination |
[44] |
YOD1 |
Functions as the DUB to antagonize the proteolytic ITCH autoubiquitination |
[45] |